Center Laboratories Inc.

05/20/2022 | Press release | Distributed by Public on 05/20/2022 06:43

To announce Directors elected by 2022 Annual Shareholders’Meeting

Close
Today's Information

Provided by: Center Laboratories, Inc.
SEQ_NO 2 Date of announcement 2022/05/20 Time of announcement 20:40:58
Subject
 To announce Directors elected by 2022 Annual
Shareholders'Meeting
Date of events 2022/05/20 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2022/05/20
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):
institutional director, independent director, natural-person director
3.Title and name of the previous position holder:
(一) Directors:
(1)Jason Biotech Co., LTD Representative: Lin, Jung Chin
(2)Cheng, Wann-Lai
(3)Chang, Po Chih
(4)Lejean Biotech Co., Ltd.
(5)Witty Mate Corporation
(6)Wechen Co. Ltd.
(7)Po Chang Investment Co., Ltd.
(二) Independent directors:
(1)Ho, Shih-Chinn
(2)Chen, Yung-Chang
(3)Ho, Mei-Yueh
4.Resume of the previous position holder:
(一)Directors:
(1)Lin, Jung Chin: Chairman of Center Laboratories, Inc.
(2)Cheng, Wann-Lai: Chairman of Browave Corp.
(3)Chang, Po Chih: Director of Public Relations Department,
BioGend Therapeutics Co., Ltd.
(4)Lejean Biotech Co., Ltd.: Director of Center Laboratories, Inc.
(5)Witty Mate Corporation: Director of Collins Co., Ltd.
(6)Wechen Co. Ltd.: Director of Center Laboratories, Inc.
(7)Po Chang Investment Co., Ltd.: Director, Chia Her Industrial Co., Ltd.
(二)Independent directors:
(1)Ho,Shih-Chinn:Director of Trade-Van Information Services Co.
(2)Chen,Yung-Chang: Independent Director of Collins Co., Ltd.
(3)Ho,Mei-Yueh:Independent Director of AU Optronics Corp.
5.Title and name of the new position holder:
(一)Directors:
(1)Jason Biotech Co., LTD Representative: Lin, Jung Chin
(2)Lejean Biotech Co., Ltd.
(3)Wechen Co. Ltd.
(4)Po Chang Investment Co., Ltd.
(5)Tsai, Chang-Hai
(6)Chang, Po Chih
(二)Independent directors:
(1)Ho, Mei-Yueh
(2)Ho, Shih-Chinn
(3)LIN SHIRLEY YI-HSIEN
6.Resume of the new position holder:
(一)Directors:
(1)Lin, Jung Chin: Chairman of Center Laboratories, Inc.
(2)Lejean Biotech Co., Ltd.: Director of Center Laboratories, Inc.
(3)Wechen Co. Ltd.: Director of Center Laboratories, Inc.
(4)Po Chang Investment Co., Ltd.: Director, Chia Her Industrial Co., Ltd.
(5)Tsai, Chang-Hai: Chairman of China Medical University Hospital System,
 Taiwan
(6)Chang, Po Chih: Director of Public Relations Department, BioGend
Therapeutics Co., Ltd.
(二)Independent directors:
(1)Ho, Mei-Yueh: Independent Director of AU Optronics Corp.
(2)Ho, Shih-Chinn: Director of Trade-Van Information Services Co.
(3)LIN SHIRLEY YI-HSIEN: Director of SciClone Pharmaceuticals (Holdings)
 Limited.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expire.
8.Reason for the change:Re-election.
9.Number of shares held by the new position holder when elected:
(一)Directors:
(1)Jason Biotech Co., LTD: 10,296,402 shares
Representative: Lin, Jung Chin: 4,197,248 shares
(2)Lejean Biotech Co., Ltd.: 43,719,920 shares
(3)Wechen Co. Ltd.: 4,571,309 shares
(4)Po Chang Investment Co., Ltd.: 57,599 shares
(5)Tsai, Chang-Hai: 0 share
(6)Chang, Po Chih: 1,939,613 shares
(二) Independent directors:
(1)Ho, Mei-Yueh: 0 share
(2)Ho, Shih-Chinn: 0 share
(3)LIN SHIRLEY YI-HSIEN: 0 share
10.Original term (from __________ to __________):
2019/06/24~2022/06/23
11.Effective date of the new appointment:2022/05/20
12.Turnover rate of directors of the same term:
term expired, not applicable.
13.Turnover rate of independent directors of the same term:
term expired, not applicable.
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None.